Hepatitis B Blood Panel: How to Read HBsAg, Anti-HBs and Anti-HBc

A hepatitis B blood panel checks HBsAg, anti-HBs and total anti-HBc, and together the results can suggest whether you are infected, immune or still susceptible. HBsAg detects the virus's surface protein and, when positive, suggests a current infection. Anti-HBs is the antibody often associated with immunity from vaccination or a past infection. Anti-HBc shows whether your immune system has met the virus. This guide explains how to read hepatitis B blood test results, what each pattern may suggest and when to seek care.

What a hepatitis B blood panel measures

Hepatitis B is a viral infection of the liver. MedlinePlus describes it as a disease that can be short-lived (acute) or long-lasting (chronic). A hepatitis B blood panel looks for pieces of the virus and for the antibodies your body makes in response. No single result tells the whole story, which is why clinicians usually order the three tests together.

• HBsAg (hepatitis B surface antigen): a protein on the surface of the virus. It is a marker of the virus itself.
• Anti-HBs (hepatitis B surface antibody): an antibody directed at that surface protein. It can develop after vaccination or after recovering from an infection.
• Anti-HBc (hepatitis B core antibody): an antibody directed at the inner core of the virus. Vaccination does not cause it, so it is a marker of exposure to the actual virus.

Labels vary. Some reports say "total anti-HBc," which counts all antibody types. Others add "IgM anti-HBc," a subtype that is often present early in an infection. Your report will also list each result as reactive/positive or nonreactive/negative, sometimes with a numeric value and the lab's own cutoff.

How to read your hepatitis B panel results

The table below shows the common patterns. It is a general guide, not a diagnosis. Clinicians combine your history, symptoms, examination and further testing before reaching a conclusion.

A positive HBsAg: what happens next

A positive HBsAg suggests the virus is present in your blood. It does not by itself say whether the infection is new or long-standing, and it does not say how much liver involvement there is. Clinicians usually repeat or extend the testing to sort this out.

Follow-up tests commonly include IgM anti-HBc, HBeAg and anti-HBe (markers that relate to how actively the virus is making copies), hepatitis B DNA (a measure of the amount of virus in the blood), and liver tests such as the ones covered in MedlinePlus: Liver Diseases and in our article Elevated Liver Enzymes: ALT and AST Explained. Some people also have an ultrasound or other liver assessment.

Most healthy adults who become infected clear the virus on their own, whereas infection acquired at birth or in early childhood is more likely to become chronic, according to the CDC. Chronic hepatitis B needs long-term follow-up with a clinician, who may monitor the liver (including surveillance for liver cancer in some people) and consider other factors such as alcohol use and coinfection with other viruses. It can cause long-term liver damage in some people, and there are prescription treatments that can reduce that risk. Whether you need treatment is a decision for you and a clinician, often a liver specialist, based on your full results. Labels for hepatitis B antivirals carry a boxed warning about severe flares of hepatitis after the medicine is stopped, so do not stop or skip doses without talking to your prescriber.

Anti-HBs: protection from vaccination or past infection

A positive anti-HBs is generally a favorable result. The lab compares your level with a cutoff, and a level above it is usually read as evidence of protection. Antibody levels can fade over the years after vaccination, and a lower result does not automatically mean you are unprotected, since immune memory may persist. If your result is below the cutoff and you have a reason to need protection (for example, health care work, a household member with hepatitis B, or planned immune-suppressing treatment), tell your clinician so they can decide whether a booster dose or a repeat vaccine series is appropriate.

Anti-HBs alone, with negative HBsAg and negative anti-HBc, is the usual fingerprint of vaccination. If you were vaccinated and never infected, anti-HBc should be negative.

Anti-HBc: the marker that vaccination does not produce

Because the vaccine contains only the surface protein, a positive total anti-HBc suggests your immune system has encountered the virus itself at some point. It can remain positive for life. With a positive anti-HBs and negative HBsAg, it usually points to a resolved infection.

IgM anti-HBc is a subtype that often appears early in an infection. A positive result alongside HBsAg may suggest an acute infection, although a clinician interprets it with symptoms and other results, since it can sometimes appear again during flares of chronic infection.

Isolated anti-HBc: when only the core antibody is positive

This pattern (HBsAg negative, anti-HBs negative, anti-HBc positive) confuses many people. Several explanations are possible, and the panel alone cannot choose among them:

• A past infection in which the surface antibody has faded below the detectable level.
• The late "window" phase of a recovering acute infection, when HBsAg has cleared but anti-HBs has not yet appeared.
• A low-level, chronic infection in which HBsAg is too low to detect. Hepatitis B DNA testing can help.
• A false-positive result, which occurs in some cases.

Clinicians often respond with hepatitis B DNA testing, repeat testing, or a vaccine dose to see whether the immune system responds. The right path depends on your risk factors and health situation.

Past hepatitis B and immune-suppressing treatment

Someone with a resolved infection can still carry hepatitis B virus in a quiet form in the liver. In people who receive chemotherapy, certain biologic drugs, high-dose steroids, or treatment before a transplant, the virus can sometimes reactivate. Reactivation can cause liver injury that ranges from mild to severe. Infection-prevention guidelines for transplant and high-dose chemotherapy patients, such as the 2016 and 2020 recommendations listed in Sources, are examples of immunosuppression-related screening. They address testing for hepatitis B before treatment and, for some people, monitoring or preventive antiviral medicine. If you have any positive anti-HBc result and a treatment of this kind is planned, tell the prescribing clinician so they can decide what monitoring suits you. Do not change or skip any prescribed treatment on your own.

Pregnancy, newborns and household contacts

The CDC recommends testing pregnant people for HBsAg, ideally at the first prenatal visit, so your obstetric clinician will usually check it. A positive result lets the care team give the newborn hepatitis B vaccine and, when indicated, hepatitis B immune globulin within 12 hours of birth, which matters because infection acquired at birth is more likely to become chronic than infection acquired later in life. If your panel shows HBsAg, tell your pediatrician before delivery. Household and sexual partners of someone with hepatitis B can ask their own clinician about testing and vaccination. Hepatitis B spreads through blood and other body fluids, not through casual contact such as hugging or sharing a meal. See MedlinePlus: Hepatitis B for an overview of transmission and prevention.

How hepatitis B differs from other causes of an abnormal liver panel

Hepatitis B is one of several viral hepatitis infections. Our article Positive Hepatitis C Antibody Test: Does It Mean I Have Hep C? covers the hepatitis C side, and hepatitis A is a separate virus with its own tests. A high bilirubin, discussed in What Does a High Bilirubin Result on a Liver Panel Mean?, can have many causes, and jaundice can come from liver, bile duct, or blood conditions. Because hepatitis B shares routes of spread with HIV and other infections, clinicians sometimes suggest testing for those as well. See MedlinePlus: Sexually Transmitted Infections for background.

Questions to bring to your appointment

• Which of my results are positive, and what pattern do they form?
• Do I need hepatitis B DNA or additional liver testing?
• Is vaccination or a booster appropriate for me?
• Does anyone in my household or any partner need testing?
• Do my medications or planned treatments change how my results should be monitored?

When to Seek Medical Care